CPH Group AG

CPHN

Equity

ISIN CH0001624714 / Valor 162471

SIX Swiss Exchange (2025-11-21)

CHF 69.40-0.86%

CPH Group AG
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

CPH Chemie + Papier Holding AG (CPH Group) is a diversified, internationally active industrial holding company that operates through independently marketed business divisions. These divisions, which include Chemistry, Paper, and Packaging, are among the top three providers in their respective sales markets. The company focuses on markets that allow for sustainable, profitable growth, leveraging technology leadership and innovative products to offer significant value to its customers and secure a leading position in its relevant market segments. The Chemistry and Packaging divisions pursue a differentiation strategy with a focus on innovation, global expansion, and continuous profitability improvements. In contrast, the Paper division, operating in a displacement market, aims for cost leadership in Switzerland and neighboring countries. CPH Group's strategic directions include expanding capacities outside Switzerland to reduce cost share in Swiss Francs, strengthening the Chemistry and Packaging divisions to counterbalance the Paper division, and growing in markets outside Europe.

Summarized from source with an LLMView SourceSector: Industrials

Overall Financial Performance

During the first half of 2025, CPH Group AG’s net sales slightly decreased by 0.5% compared to the prior-year period. Despite adverse factors such as a strong Swiss franc and a challenging market environment, the Group sustained stable earnings with an EBITDA margin of 17.2%. The net result declined by CHF 4.0 million from 2024, reflecting the impact of non-recurring items from the previous period and increased financial expenses.

Zeochem Performance

Zeochem reported net sales of CHF 57.5 million, down 7.2% on a reported basis, although factors like lower raw material prices and cautious customer ordering played a role. However, EBITDA significantly improved by 17.4% to CHF 12.2 million, supported by strong integration progress of the Sorbchem acquisition in India and increased operational efficiency at its Rüti and Louisville facilities.

Perlen Packaging Update

Perlen Packaging recorded net sales of CHF 118.4 million, a 3.1% increase, bolstered by the acquisition of LOG Pharma that expanded its reach into the Israeli and Hungarian pharmaceutical packaging markets. Despite this, EBITDA declined by 12.6% to CHF 17.8 million due to adverse currency impacts, a less favourable product mix, and higher costs following the spin-off of the Paper Division.

Balance Sheet & Outlook

At the end of the first half of 2025, CPH Group AG maintained a solid balance sheet with net debt of CHF 30.3 million and an equity ratio of 54.3%. The Group confirmed its outlook for 2025, expecting a slight improvement in full-year earnings relative to 2024, driven by ongoing integration, strategic investments, and market expansion initiatives in both business segments.

Summarized from source with an LLMView Source

Key figures

3.27%1Y

25.4%3Y

51.0%5Y

Performance

26.4%1Y

23.4%3Y

23.5%5Y

Volatility